Zobrazeno 1 - 10 of 63 pro vyhledávání: '"Triviño Jc"'
1
Circulating mitochondrial genes detect acute cardiac allograft rejection: Role of the mitochondrial calcium uniporter complex
Autor: Tarazón E, Pérez-Carrillo L, García-Bolufer P, Triviño JC, Feijóo-Bandín S, Lago F, Ramón González-Juanatey J, Martínez-Dolz L, Portolés M, Roselló-Lletí E
Publikováno v: AMERICAN JOURNAL OF TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Acute rejection after heart transplantation increases the risk of chronic dysfunction. Disturbances in mitochondrial function may play a contributory role, however, the relationship between histological signs of rejection in the human transplanted he
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::04f3ab346ebdbdbf632b581ffff250dc
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13139
Zobrazit plný text záznamu
2
Species Connectivities and Reaction Mechanisms from Neutral Response Experiments
Autor: Marcel Ovidiu Vlad, John Ross, Federico Morán, Triviño Jc, Bustos M
Publikováno v: The Journal of Physical Chemistry A. 111:1844-1851
We develop a new method for obtaining connectivity data for nonlinear reaction networks, based on linear response experiments. In our approach the linear response is not the result of an approximation procedure but is due to the appropriate design of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da1a84867103060d2267b8a2a2262cd
https://doi.org/10.1021/jp0661793
Zobrazit plný text záznamu
3
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy
Autor: Herrer I, Roselló-Lletí E, Ortega A, Tarazón E, Molina-Navarro MM, Triviño JC, Martínez-Dolz L, Almenar L, Lago F, Sánchez-Lázaro I, González-Juanatey JR, Salvador A, Portolés M, Rivera M
Publikováno v: BMC MEDICAL GENOMICS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Background: Ischemic cardiomyopathy (ICM) is characterized by transcriptomic changes that alter cellular processes leading to decreased cardiac output. Because the molecular network of ICM is largely unknown, the aim of this study was to characterize
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::6998fbc26ff489882bee6dbdfe2ffb6e
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1371
Zobrazit plný text záznamu
5
RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure
Autor: Herrer I, Roselló-Lletí E, Rivera M, Molina-Navarro MM, Tarazón E, Ortega A, Martínez-Dolz L, Triviño JC, Lago F, González-Juanatey JR, Bertomeu V, Montero JA, Portolés M
Publikováno v: LABORATORY INVESTIGATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Changes in cardiomyocyte cytoskeletal components, a crucial scaffold of cellular structure, have been found in heart failure (HF); however, the altered cytoskeletal network remains to be elucidated. This study investigated a new map of cytoskeleton-l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::07dac83049d35a05c539bfa3a6b6b026
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1356
Zobrazit plný text záznamu
6
RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy
Autor: Tarazón E, Roselló-Lletí E, Rivera M, Ortega A, Molina-Navarro MM, Triviño JC, Lago F, González-Juanatey JR, Orosa P, Montero JA, Salvador A, Portolés M
Publikováno v: Plos One
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Background: The atrium is the major site of ANP synthesis, which has been said to increase in heart failure as a result of increased production in the left ventricular (LV) myocardium. This is a key issue related to its diagnostic and prognostic capa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::af3dc93700da1d24a27b0d0b6a0782c6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1355
Zobrazit plný text záznamu
7
Functional Networks of Nucleocytoplasmic Transport-Related Genes Differentiate Ischemic and Dilated Cardiomyopathies. A New Therapeutic Opportunity
Autor: Molina-Navarro MM, Triviño JC, Martínez-Dolz L, Lago F, González-Juanatey JR, Portolés M, Rivera M
Publikováno v: Plos One
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Heart failure provokes alterations in the expression of nucleocytoplasmic transport-related genes. To elucidate the nucleocytoplasmic transport-linked functional network underlying the two major causes of heart failure, ischemic cardiomyopathy (ICM)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::32adb7aaae595f8854da111fc1b2d3c2
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1358
Zobrazit plný text záznamu
8
Akademický článek
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation.
Autor: Muñiz P; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Martínez-García M; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain.; Department of Signal Theory and Communications, University Carlos III of Madrid, Madrid, Spain., Bailén R; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Chicano M; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Oarbeascoa G; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Triviño JC; Bioinformatic Department, Sistemas Genómicos, Valencia, Spain., de la Iglesia-San Sebastian I; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Fernández de Córdoba S; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Anguita J; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Kwon M; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Díez-Martín JL; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain.; Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain., Olmos PM; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain.; Department of Signal Theory and Communications, University Carlos III of Madrid, Madrid, Spain., Martínez-Laperche C; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain., Buño I; Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain.; Signal Theory and Communications Department, School of Engineering, Carlos III University, Leganés, Madrid, Spain.; Genomics Unit, Gregorio Marañón General University Hospital, IiSGM, Madrid, Spain.; Department of Cell Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Aug 23; Vol. 15, pp. 1396284. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Report
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis.
Autor: Malhotra S; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Fissolo N; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Rodríguez-Rivera C; Area of Pharmacology and Nutrition & Bromatology, Department of Basic Health Sciences, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain., Monreal E; Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain., Montpeyo M; Neurodegenerative Diseases Research Group, Institut de Recerca Vall d'Hebron (VHIR) - Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain., Urcelay E; Laboratorio de Investigación en Genética de Enfermedades Complejas, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain., Triviño JC; Genomic Systems, Valencia, Spain., Pérez-García MJ; Group of Childhood Cancer and Blood Disorders, Institut de Recerca Vall d'He, bron (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Segura MF; Group of Childhood Cancer and Blood Disorders, Institut de Recerca Vall d'He, bron (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Pappolla A; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Río J; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Vilaseca A; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Fernández Velasco JI; Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain., Miguez A; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Goicoechea C; Area of Pharmacology and Nutrition & Bromatology, Department of Basic Health Sciences, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain., Martinez-Vicente M; Neurodegenerative Diseases Research Group, Institut de Recerca Vall d'Hebron (VHIR) - Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Barcelona, Spain., Villar LM; Department of Neurology, Hospital Universitario Ramón y Cajal, REEM, IRYCIS, Universidad de Alcalá, Madrid, Spain., Montalban X; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain., Comabella M; Servei de Neurologia. Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain.
Publikováno v: Clinical and translational medicine [Clin Transl Med] 2024 Apr; Vol. 14 (4), pp. e1654.
Zobrazit plný text záznamu
10
Report
Transcriptomics reveals new regulatory mechanisms involved in benralizumab response.
Autor: Estravís M; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain., Pérez-Pazos J; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit, Hospital Universitario de Salamanca, Salamanca, Spain., Moreno-Jimenez E; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Microbiology and Genetics Department Salamanca, Universidad de Salamanca, Salamanca, Spain., Triviño JC; Synlab Group, Sistemas Genómicos SL, Valencia, Spain., García-Sánchez A; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.; Biomedical and Diagnostics Sciences Department, Universidad de Salamanca, Salamanca, Spain., Gómez-García M; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit, Hospital Universitario de Salamanca, Salamanca, Spain., Morgado N; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Biomedical and Diagnostics Sciences Department, Universidad de Salamanca, Salamanca, Spain., Ramos-González J; Pneumology Department, Hospital Universitario de Salamanca, Salamanca, Spain., Gil-Melcón M; Otorhinolaryngology and Head and Neck Surgery Department, Hospital Universitario de Salamanca, Salamanca, Spain., Martín-García C; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain., Muñoz-Bellido F; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.; Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain., Sanz C; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.; Microbiology and Genetics Department Salamanca, Universidad de Salamanca, Salamanca, Spain., Isidoro-García M; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.; Medicine Department, Universidad de Salamanca, Salamanca, Spain.; Clinical Biochemistry Department, Hospital Universitario de Salamanca, Salamanca, Spain., Dávila I; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.; Synlab Group, Sistemas Genómicos SL, Valencia, Spain.; Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain.
Publikováno v: Allergy [Allergy] 2023 Nov; Vol. 78 (11), pp. 3023-3026. Date of Electronic Publication: 2023 Aug 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje